Abstract
Breast cancer screening trials have provided the first clear evidence that early treatment can prolong life. The trials, in order to provide valid evidence on whether life is prolonged, have been based on comparisons of mortality from breast cancer in defined populations followed over several years. Results from two such populationbased trials of breast cancer screening (one in New York, the HIP study [1], the other in Sweden, the Two Counties study [2] have, so far, been published and both show a 30% reduction in breast cancer mortality attributable to screening.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shapiro, S. (1977). Evidence on screening for breast cancer from a randomised trial. Cancer, 39, 2772–2782.
Tabar, L., Fagerberg, C.J.G., Gad, A. et al. (1985). Reduction in mortality from breast cancer after mass screening with mammography. Lancet, i, 829–832.
Collette, HJ.A., Day, N.E., Rombach, JJ., de Waard, F. (1984). Evaluation of screening for breast cancer in a non-randomised study (the DOM Project) by means of a case-control study. Lancet, i, 1224–1226.
Verbeek, A.L.M., Hendricks, J.H.C.L. et al. (1984). Reduction in breast cancer mortality through mass screening with modern mammography. (First results of the Nijmegan Project, 1975–81). Lancet, i, 1222–1224.
Palli, D., Roselli del Turco, M. et al. (1986). A case-control study of the efficacy of a non-randomised breast cancer screening program in Florence (Italy). Int. J. Cancer, 38, 501–504.
Day, N.E., Chamberlain, J. (1988). Screening for breast cancer: Workshop Report. Eur. J. Cancer Oncol., 24, 55–59.
Working Group, Chariman• Forrest, P. (1987). Breast Cancer Screening. Report to the Health Ministers of England Wales, Scotland and Northern Ireland, HMSO, London.
Tabar, L., Fagerberg, G., Day, N.E., Holmberg, L. (1987). What is the optimum interval between mammographie screening examinations? Brit. J. Cancer, 55, 547–551.
Bailar, J. (1988). Mammography before 50 years? J. Amer. Med. Ass., 259, 1548–1549.
US Preventive Services Task Force (1987). Recommendations for breast cancer screening. J. Amer. Med. Ass., 257, 2196.
Miller, A.B., Howe, G.R., Wall, C. (1981). The national study of breast cancer screening: protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin. Invest. Med, 4, 227–258.
Mant, D, Vessey, M.P., Neil, A., McPherson K., Jones, L. (1987). Breast self-examination and breast cancer stage at diagnosis. Brit. J. Cancer. 55,207–211.
Baines, C.J. (1983). Some thoughts on why women don’t do breast self-examination. Canad. Med. Ass. J., 128, 255–256.
Sickles, E.A., Filly, F.A., Callen, P.W. (1983). Breast cancer detection with ultrasonography and mammography: comparison using state-of-the-art equipment. AJR, 140, 843–845.
Gravelle, H.S.E., Simpson, P.R., Chamberlain, J. (1982). Breast cancer screening and health service costs. J. Hlth. Econ., 1, 185–207.
Laara, E., Day, N.E., Hakama, M. (1987). Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet, 1, 1247–1249.
Alexander, F.E., Roberts, M.M., Huggins, A., Muir, B. (In press). The use of risk factors to allocate schedules for breast cancer screening. J. Epidem. Conunun. Hltl.
Feig, S.A. (1984). Benefits and risks of mammography. Recent Results in Cancer Research, 90, 11–27.
Moskowitz, M., Garside, P. (1982). Evidence of breast cancer mortality reduction: aggressive screening in women under age 50. AJR, 138, 911–916.
Nielsen, M., Thomsen, J., Primdahl, S., Dyreborg, U., Andersen, J. (1987). Breast cancer and atypia among young and middle-aged women: a study of 100 medico-legal autopsies. Brit. J. Cancer, 56, 814–819.
Skrabanek, P. (1988). The physician’s responsibility to the patient. Lancet, i, 1155–1156.
Maclean, U., Sinfield, D., Klein, S., Harnden, B. (1984). Women who decline breast screening. J. Epidem. Commun. Hlth., 38, 278–283.
Hall, F.M. (1986). Screening mammography–potential problems on the horizon. New Engl. J. Med., 314, 53–55.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ellman, R. (1989). Clinical Cost-Benefit of Screening Programmes. In: Stoll, B.A. (eds) Women at High Risk to Breast Cancer. Developments in Oncology, vol 57. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1327-1_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-1327-1_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7091-1
Online ISBN: 978-94-009-1327-1
eBook Packages: Springer Book Archive